Palantir Technologies has digested its June 3 earnings event and the picture that emerges is one of validated fundamentals meeting a stock that had already priced in a lot of good news.
The print landed with the stock at $152.17 — down 5.3% on the day, extending the pattern established at the May Q1 release when the stock also fell 5.7% the next session. That symmetry is worth noting. Palantir has now delivered back-to-back single-day drops of roughly the same magnitude after earnings events, even as the five-day windows around those prints have been less punishing (-5.0% and now running). The week as a whole still shows an 11.4% gain, capturing the pre-print run-up. The stock entered June 3 at $160.65 after a 17% weekly surge. Bulls who held through the event collected most of that move; those who chased the day-of high found themselves offside fast. The month-on-month picture remains constructive at +5.6%, and the narrative around AI platform leadership is intact — but the path from here looks more selective.
Options positioning has shifted meaningfully relative to the pre-print setup. The put/call ratio has eased to 0.94 — still below the 20-day average of 1.01, but the z-score has moved to -2.17. That means call positioning, while still elevated, is fading from the extreme bullish skew flagged in the previous note. The 52-week PCR range runs from 0.61 to 1.16. At 0.94, the market is no longer paying aggressively for upside tail exposure — the event has passed and the options market has begun to normalise. The borrow market remains entirely without friction: availability sits at 8,568%, meaning there are roughly 85 shares available for every one currently lent out. Cost to borrow is 0.42%, unchanged in practical terms. There is no squeeze pressure and no structural incentive for forced covers.
Short interest has re-accelerated since the print. SI % FF climbed back to 2.98% — up 13.7% on the week and now 26.9% above where it was a month ago. The trajectory is a clear reversal from the mid-May pullback flagged in earlier notes: shorts had eased from 2.73% to 2.62% in late May, then rebuilt aggressively into and through the earnings date. The absolute level remains low, and the borrow conditions described above mean there is no mechanical pressure on this short base. This is a conviction short at a cheap carry cost, not a distressed one. The ORTEX short score of 31.8 is consistent with that read — elevated relative to early April but well short of crowded.
The Street remains deeply split. Bulls cluster at targets of $225–$230 (Wedbush, Rosenblatt, Citigroup — which lifted its target to $225 from $210 after the May print). Bears are anchored by RBC's $90 Underperform. The consensus sits at Hold with a mean target of $185. At $152, that implies theoretical upside to consensus — but that target pool reflects analyst dispersion so wide as to be almost meaningless as a standalone signal. The earnings disappointment gave the cautious side some cover: DA Davidson trimmed its target to $165 from $180 while holding Neutral, and HSBC downgraded to Hold before the print with a $151 target that now sits essentially at-the-money. EV/EBITDA has compressed 12.7 points over 30 days to 64.6x, and the PE has drifted back to 88.5x. These are still demanding multiples for a stock that just fell 5% post-earnings, but the growth case — EPS momentum ranking in the 92nd percentile on a 30-day basis and 85th on 90-day — provides the scaffolding bulls need.
CEO Alex Karp sold roughly $19.9 million of stock at prices around $133–$137 on May 20, as noted in previous notes, under a pre-arranged trading plan. That sale occurred well below the post-print highs and is plan-driven, limiting its informational value. The broader 90-day net insider picture shows net selling of approximately $124 million in value terms — a consistent theme for Palantir where founder-level sales are structural rather than episodic. Peers broadly tracked the post-event decline: CLBT fell 5.6% on the day while CGNT dropped 5.1%, suggesting broad sector pressure rather than a Palantir-specific selloff. APP held notably better, off just 1.3%.
The next scheduled earnings event is August 3. Between now and then, the key variable is whether the short rebuild — now at its fastest monthly pace in the dataset — continues to gather pace as the stock settles into a post-print range, or whether the fundamentals case resets positioning closer to where it was in April.
See the live data behind this article on ORTEX.
Open PLTR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.